| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 1-20, 2019 | 289 | 2019 |
| Quantitative analysis of endogenous compounds R Thakare, YS Chhonker, N Gautam, JA Alamoudi, Y Alnouti Journal of pharmaceutical and biomedical analysis 128, 426-437, 2016 | 199 | 2016 |
| Creation of a long-acting nanoformulated dolutegravir B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ... Nature communications 9 (1), 443, 2018 | 110 | 2018 |
| Species differences in bile acids I. Plasma and urine bile acid composition R Thakare, JA Alamoudi, N Gautam, AD Rodrigues, Y Alnouti Journal of applied toxicology 38 (10), 1323-1335, 2018 | 100 | 2018 |
| Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders P Coiro, R Padmashri, A Suresh, E Spartz, G Pendyala, S Chou, Y Jung, ... Brain, behavior, and immunity 50, 249-258, 2015 | 100 | 2015 |
| Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ... Biomaterials 151, 53-65, 2018 | 93 | 2018 |
| A year-long extended release nanoformulated cabotegravir prodrug TA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ... Nature materials 19 (8), 910-920, 2020 | 80 | 2020 |
| Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy N Gautam, U Roy, S Balkundi, P Puligujja, D Guo, N Smith, XM Liu, ... Antimicrobial agents and chemotherapy 57 (7), 3110-3120, 2013 | 75 | 2013 |
| Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ... The Journal of infectious diseases 206 (10), 1577-1588, 2012 | 71 | 2012 |
| Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells GD Kanmogne, S Singh, U Roy, X Liu, JE McMillan, S Gorantla, ... International journal of nanomedicine, 2373-2388, 2012 | 64 | 2012 |
| Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects SPR Bathena, R Thakare, N Gautam, S Mukherjee, M Olivera, J Meza, ... Toxicological sciences 143 (2), 296-307, 2015 | 58 | 2015 |
| Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs DP Gnanadhas, PK Dash, B Sillman, AN Bade, Z Lin, DL Palandri, ... The Journal of clinical investigation 127 (3), 857-873, 2017 | 57 | 2017 |
| Creation of a long-acting nanoformulated 2′, 3′-dideoxy-3′-thiacytidine D Guo, T Zhou, M Araínga, D Palandri, N Gautam, T Bronich, Y Alnouti, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 74 (3), e75-e83, 2017 | 55 | 2017 |
| Development and characterization of a long-acting nanoformulated abacavir prodrug D Singh, JE McMillan, J Hilaire, N Gautam, D Palandri, Y Alnouti, ... Nanomedicine 11 (15), 1913-1927, 2016 | 53 | 2016 |
| Species differences in bile acids II. Bile acid metabolism R Thakare, JA Alamoudi, N Gautam, AD Rodrigues, Y Alnouti Journal of applied toxicology 38 (10), 1336-1352, 2018 | 50 | 2018 |
| UPLC–MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues J Huang, N Gautam, SPR Bathena, U Roy, JE McMillan, HE Gendelman, ... Journal of Chromatography B 879 (23), 2332-2338, 2011 | 47 | 2011 |
| Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy P Radhakrishnan, VC Bryant, EC Blowers, RN Rajule, N Gautam, ... Clinical cancer research 19 (8), 2025-2035, 2013 | 40 | 2013 |
| Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean … RR Wakaskar, SPR Bathena, SB Tallapaka, VV Ambardekar, N Gautam, ... Pharmaceutical research 32, 1028-1044, 2015 | 39 | 2015 |
| Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients SPR Bathena, R Thakare, N Gautam, S Mukherjee, M Olivera, J Meza, ... Toxicological sciences 143 (2), 308-318, 2015 | 39 | 2015 |
| Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir N Gautam, JEM McMillan, D Kumar, AN Bade, Q Pan, TA Kulkarni, W Li, ... Nature communications 12 (1), 3453, 2021 | 37 | 2021 |
